Market

Eargo raises capital to compete in the OTC arena

 

Over-the-counter

Eargo

US hearing aid maker, Eargo, has raised $32.3 million to help it compete in the effervescent over-the-counter (OTC) market.

Read more...

Demant's divestment of Oticon Medical to Cochlear could be delayed by Australia competition regulation concerns

 
 
 

implants

Cochlear      A recipient of a Cochlear Osia System active bone conduction solution, with an Aqua+ accessory

Danish hearing giant Demant is confident it can resolve concerns by the Australian Competition and Consumer Commission (ACCC) that its planned divestment of Oticon Medical to Cochlear may have a negative impact on implant consumers by lessening competition, reducing innovation, and pushing up prices.

Read more...

The future of hearing technology lies in GETTING CLOSER TO THE USER

 

technology

MarioGuti - iStock

BIHIMA interviewed Sebastian Best, Head of Sound and Fitting in the Research and Development Department of Signia. Having worked for the company for almost 15 years, Sebastian has a wealth of experience in hearing technology development and discusses how processing strategies help people with hearing loss.

Read more...

WIDEX MOMENT App Named CES 2023 Innovation Awards Honouree

 
 

awards

Widex

The WS Audiology brand Widex has announced that it has been named a CES 2023 Innovation Awards Honouree for its WIDEX MOMENT smartphone app.

Read more...

Audiology Conferences 2022: EUHA - Still the biggest audiology event in the world

 
 

conferences

EUHA/Foto Rechtnitz EUHA President Beate Gromke (centre right) cuts the tape to symbolise the opening of the 2022 Congress.

One of the most welcome signs of the audiology sphere's recovery from the ravages of Covid-19 is the return of conferences, and this year's EUHA Congress in Hanover, Germany showed it is getting back to previous highs as the biggest hearing event of them all. Organisers registered an overall count of 7,400 visitors, which means the show's pre-pandemic target of 9,000 is again in sight.

Read more...

Demant grows its shares of GN Store Nord, while latter gives its shareholders a gloomy audio division forecast

 

financials

GN Hearing

GN Store Nord has announced that it received a notification from William Demant Invest stating that William Demant Invest A/S increased its aggregate holding of shares to above 10% of the share capital and voting rights in GN Store Nord A/S.

Read more...

USA's Lively rebrands as Jabra Enhance as GN shuffles its OTC pack

 
 

brand shifts

GN Hearing

GN Hearing has thickened the imprint of its OTC offering by rebranding Lively, an online teleaudiology purchase it made in 2021, which will now take the name of GN's flagship over-the-counter hearing aid, Jabra Enhance.

Read more...

Hewlett Packard moves into hearing space with Nuheara

 

OTC

HP

Australian firm Nuheara is the latest manufacturer to launch an over-the-counter (OTC) hearing device, trading blows in the early rounds of an inevitable price war, but choosing to license not under its own name but through a well known partner, Hewlett Packard's HP brand.

Read more...

A live debate in Spain reviews the possible consequences of OTC hearing aids - from hearing aid allies to cortical damage

 
 

Over-the-counter

JLF      Jordi Serra, Raúl García-Medina, Guillermina Achleitner and Alfonso Ríos at the AEDA round table discussion on OTC hearing aids.

It’s a hot topic. The US Food and Drug Administration announced its final ruling and guidance on over-the-counter hearing aids in August 2022. Since then, major manufacturers have announced product for the self-fitting direct-to-consumer space opened up by the ruling, first in the US, and then, by creep, to the rest of the world.

Read more...

Amplifon boasts "ideal positioning" on release of solid Q3 2022 results

 
 

chains

Roger Mechan - iStock

Amplifon, the world's biggest hearing aid retailer, has posted strong third quarter figures, supporting the Milan-based group's forecast of end-of-year revenues in the region of 2,150 million euros, and an EBITDA recurring margin in the region of 25%.

Read more...